Structure–Activity Relationship Study of CYM51010, an Agonist for the µ–δ Opioid Receptor Heterodimer-Reference-Cited by-同舟云学术

Structure–Activity Relationship Study of CYM51010, an Agonist for the µ–δ Opioid Receptor Heterodimer

Published:2024-07-30 Issue:7 Volume:72 Page:711-730
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:Chem. Pharm. Bull.

Author:

Watanabe Ayaka¹,Yamada Shuma¹,Yoshida Haruka¹²,Inagaki Miku¹²,Atsumi Nao¹²,Matsushima Aoba¹,Takahashi Naoki¹,Ishibashi Naoto¹²,Ogino Takumi¹²,Someya Ryoto¹²,Taguchi Ai¹²,Kagaya Ryo¹²,Ashizawa Karin¹²,Mendori Hinako²³,Karasawa Yusuke²,Ohshima Kaori²,Yokoyama Akinobu³,Nonaka Miki²,Miyano Kanako²,Karaki Fumika¹⁴,Hirayama Shigeto¹⁴,Itoh Kennosuke¹⁴,Uezono Yasuhito²,Fujii Hideaki¹⁴

Affiliation:

1. Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University

2. Department of Pain Control Research, The Jikei University School of Medicine

3. Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science

4. Medicinal Research Laboratories, School of Pharmacy, Kitasato University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/cpb/72/7/72_c24-00188/_pdf

Reference47 articles.

1. 1) Devereaux A. L., Mercer S. L., Cunningham C. W., ACS Chem. Neurosci., 9, 2395–2407 (2018).

2. 2) Burns S. M., Cunningham C. W., Mercer S. L., ACS Chem. Neurosci., 9, 2428–2437 (2018).

3. 3) Morgan M. M., Christie M. J., Br. J. Pharmacol., 164, 1322–1334 (2011).

4. 4) Volkow N. D., Collins F. S., N. Engl. J. Med., 377, 391–394 (2017).

5. 5) Soergel D. G., Subach R. A., Burnham N., Lark M. W., James I. E., Sadler B. M., Skobieranda F., Violin J. D., Webster L. R., Pain, 155, 1829–1835 (2014).